Referências
Principais artigos
Thompson BG, Brown RD Jr, Amin-Hanjani S, et al. Guidelines for the management of patients with unruptured intracranial aneurysms: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015 Aug;46(8):2368-400.Texto completo Resumo
Hoh BL, Ko NU, Amin-Hanjani S, et al. 2023 Guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke. 2023 Jul;54(7):e314-70.Texto completo Resumo
Steiner T, Juvela S, Unterberg A, et al. European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis. 2013 Feb 7;35(2):93-112.Texto completo Resumo
Artigos de referência
1. Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med. 2006 Jan 26;354(4):387-96.
2. Polmear A. Sentinel headaches in aneurysmal subarachnoid haemorrhage: what is the true incidence? A systematic review. Cephalalgia. 2003 Dec;23(10):935-41. Resumo
3. Leblanc R. The minor leak preceding subarachnoid hemorrhage. J Neurosurg. 1987 Jan;66(1):35-9. Resumo
4. Beck J, Raabe A, Szelenyi A, et al. Sentinel headache and the risk of rebleeding after aneurysmal subarachnoid hemorrhage. Stroke. 2006 Nov;37(11):2733-7. Resumo
5. Pereira JL, de Albuquerque LA, Dellaretti M, et al. Importance of recognizing sentinel headache. Surg Neurol Int. 2012;3:162.Texto completo Resumo
6. Hughes JD, Bond KM, Mekary RA, et al. Estimating the global incidence of aneurysmal subarachnoid hemorrhage: a systematic review for central nervous system vascular lesions and meta-analysis of ruptured aneurysms. World Neurosurg. 2018 Jul;115:430-447.e7.Texto completo Resumo
7. Claassen J, Park S. Spontaneous subarachnoid haemorrhage. Lancet. 2022 Sep 10;400(10355):846-62.Texto completo Resumo
8. Linn FH, Rinkel GJ, Algra A, et al. Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke. 1996 Apr;27(4):625-9. Resumo
9. Bruno A, Qualls C. Risk factors for intracerebral and subarachnoid hemorrhage among Hispanics and non-Hispanic whites in a New Mexico community. Neuroepidemiology. 2000 Jul-Aug;19(4):227-32. Resumo
10. Etminan N, Chang HS, Hackenberg K, et al. Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis. JAMA Neurol. 2019 May 1;76(5):588-97.Texto completo Resumo
11. Kassell NF, Torner JC, Haley EC Jr, et al. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: overall management results. J Neurosurg. 1990 Jul;73(1):18-36. Resumo
12. Kassell NF, Torner JC, Jane JA, et al. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: surgical results. J Neurosurg. 1990 Jul;73(1):37-47. Resumo
13. Broderick JP, Brott T, Tomsick T, et al. The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N Engl J Med. 1992 Mar 12;326(11):733-6. Resumo
14. Adams HP, Davis P. Aneurysmal subarachnoid hemorrhage. In: Mohr JP, Choi D, Grotta J, et al, eds. Stroke: pathophysiology, diagnosis and management. London: Churchill Livingstone; 2004:377-96.
15. van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: diagnosis, causes and management. Brain. 2001 Feb;124(2):249-78.Texto completo Resumo
16. Brisman JL, Song JK, Newell DW. Cerebral aneurysms. N Engl J Med. 2006 Aug 31;355(9):928-39.
17. Wiebers DO, Piepgras DG, Meyer FB, et al. Pathogenesis, natural history, and treatment of unruptured intracranial aneurysms. Mayo Clin Proc. 2004 Dec;79(12):1572-83. Resumo
18. Aoki T, Nishimura M. Targeting chronic inflammation in cerebral aneurysms: focusing on NF-kappaB as a putative target of medical therapy. Expert Opin Ther Targets. 2010 Mar;14(3):265-73. Resumo
19. Wermer MJ, van der Schaaf IC, Velthuis BK, et al. Follow-up screening after subarachnoid haemorrhage: frequency and determinants of new aneurysms and enlargement of existing aneurysms. Brain. 2005 Oct;128(10):2421-9. Resumo
20. Backes D, Rinkel GJ, Laban KG, et al. Patient- and aneurysm-specific risk factors for intracranial aneurysm growth: a systematic review and meta-analysis. Stroke. 2016 Apr;47(4):951-7.Texto completo Resumo
21. Brinjikji W, Zhu YQ, Lanzino G, et al. Risk factors for growth of intracranial aneurysms: a systematic review and meta-analysis. AJNR Am J Neuroradiol. 2016 Apr;37(4):615-20.Texto completo Resumo
22. Can A, Du R. Association of hemodynamic factors with intracranial aneurysm formation and rupture: systematic review and meta-analysis. Neurosurgery. 2016 Apr;78(4):510-20. Resumo
23. Connolly ES, Solomon RA. Management of unruptured aneurysms. In: Le Roux PD, Winn HR, Newell DW, eds. Management of cerebral aneurysms. Philadelphia, PA: Saunders; 2004:271-85.
24. International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms - risk of rupture and risks of surgical intervention. N Engl J Med. 1998 Dec 10;339(24):1725-33.Texto completo Resumo
25. Thompson BG, Brown RD Jr, Amin-Hanjani S, et al. Guidelines for the management of patients with unruptured intracranial aneurysms: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015 Aug;46(8):2368-400.Texto completo Resumo
26. Juvela S, Porras M, Poussa K. Natural history of unruptured intracranial aneurysms: probability of and risk factors for aneurysm rupture. J Neurosurg. 2000 Sep;93(3):379-87. Resumo
27. Tsutsumi K, Ueki K, Morita A, et al. Risk of rupture from incidental cerebral aneurysms. J Neurosurg. 2000 Oct;93(4):550-3. Resumo
28. Wiebers DO, Whisnant JP, Huston J 3rd, et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003 Jul 12;362(9378):103-10. Resumo
29. Rinkel GJ. Intracranial aneurysm screening: indications and advice for practice. Lancet Neurol. 2005 Feb;4(2):122-8. Resumo
30. Broderick JP, Viscoli CM, Brott T, et al; Hemorrhagic Stroke Project Investigators. Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable. Stroke. 2003 Jun;34(6):1375-81. Resumo
31. Feigin VL, Rinkel GJ, Lawes CM, et al. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke. 2005 Dec;36(12):2773-80. Resumo
32. Juvela S. Prehemorrhage risk factors for fatal intracranial aneurysm rupture. Stroke. 2003 Aug;34(8):1852-7. Resumo
33. Qureshi AI, Suri MF, Yahia AM, et al. Risk factors for subarachnoid hemorrhage. Neurosurgery. 2001 Sep;49(3):607-12. Resumo
34. Teunissen LL, Rinkel GJ, Algra A, et al. Risk factors for subarachnoid hemorrhage: a systematic review. Stroke. 1996 Mar;27(3):544-9.Texto completo Resumo
35. Etminan N, de Sousa DA, Tiseo C, et al. European Stroke Organisation (ESO) guidelines on management of unruptured intracranial aneurysms. Eur Stroke J. 2022 Sep;7(3):V.Texto completo Resumo
36. Schievink WI, Michels VV, Piepgras DG. Neurovascular manifestations of heritable connective tissue disorders. A review. Stroke. 1994 Apr;25(4):889-903. Resumo
37. Hoh BL, Ko NU, Amin-Hanjani S, et al. 2023 Guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke. 2023 Jul;54(7):e314-70.Texto completo Resumo
38. Axelrod KA, Diringer MN. Medical management of subarachnoid hemorrhage. In: Bhardwaj A, Alkayed NJ, Kirsch JR, et al, eds. Acute stroke: bench to bedside. New York, NY: Informa Healthcare; 2006.
39. Steiner T, Juvela S, Unterberg A, et al. European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis. 2013 Feb 7;35(2):93-112.Texto completo Resumo
40. Brilstra EH, Rinkel GJ, Algra A, et al. Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage. Neurology. 2000 Dec 12;55(11):1656-60. Resumo
41. Ibrahim GM, Fallah A, Macdonald RL. Clinical, laboratory, and radiographic predictors of the occurrence of seizures following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2013 Aug;119(2):347-52. Resumo
42. Clusmann H, Schaller C, Schramm J. Fixed and dilated pupils after trauma, stroke, and previous intracranial surgery: management and outcome. J Neurol Neurosurg Psychiatry. 2001 Aug;71(2):175-81.Texto completo Resumo
43. McCarron MO, Alberts MJ, McCarron P. A systematic review of Terson's syndrome: frequency and prognosis after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2004 Mar;75(3):491-3.Texto completo Resumo
44. Tung P, Kopelnik A, Banki N, et al. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke. 2004 Feb;35(2):548-51. Resumo
45. Zaroff JG, Rordorf GA, Newell JB, et al. Cardiac outcome in patients with subarachnoid hemorrhage and electrocardiographic abnormalities. Neurosurgery. 1999 Jan;44(1):34-9. Resumo
46. Zaroff JG, Rordorf GA, Ogilvy CS, et al. Regional patterns of left ventricular systolic dysfunction after subarachnoid hemorrhage: evidence for neurally mediated cardiac injury. J Am Soc Echocardiogr. 2000 Aug;13(8):774-9. Resumo
47. Jain R, Deveikis J, Thompson BG. Management of patients with stunned myocardium associated with subarachnoid hemorrhage. AJNR Am J Neuroradiol. 2004 Jan;25(1):126-9. Resumo
48. Al-Shahi R, White PM, Davenport RJ, et al. Clinical review: subarachnoid haemorrhage. BMJ. 2006 Jul 29;333(7561):235-40.
49. Solenski NJ, Haley EC Jr, Kassell NF, et al. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med. 1995 Jun;23(6):1007-17. Resumo
50. Deibert E, Barzilai B, Braverman AC, et al. Clinical significance of elevated troponin I levels in patients with nontraumatic subarachnoid hemorrhage. J Neurosurg. 2003 Apr;98(4):741-6. Resumo
51. Bulsara KR, McGirt MJ, Liao L, et al. Use of the peak troponin value to differentiate myocardial infarction from reversible neurogenic left ventricular dysfunction associated with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003 Mar;98(3):524-8. Resumo
52. American College of Radiology. ACR Appropriateness Criteria®: headache. 2022 [internet publication].Texto completo
53. Perry JJ, Stiell IG, Sivilotti ML, et al. Clinical decision rules to rule out subarachnoid hemorrhage for acute headache. JAMA. 2013 Sep 25;310(12):1248-55.Texto completo Resumo
54. Latchaw RE, Silva P, Falcone SF. The role of CT following aneurysmal rupture. Neuroimaging Clin N Am. 1997 Nov;7(4):693-708. Resumo
55. Perry JJ, Stiell IG, Sivilotti ML, et al. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage: prospective cohort study. BMJ. 2011 Jul 18;343:d4277.Texto completo Resumo
56. Backes D, Rinkel GJ, Kemperman H, et al. Time-dependent test characteristics of head computed tomography in patients suspected of nontraumatic subarachnoid hemorrhage. Stroke. 2012 Aug;43(8):2115-9.Texto completo Resumo
57. Dubosh NM, Bellolio MF, Rabinstein AA, et al. Sensitivity of early brain computed tomography to exclude aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Stroke. 2016 Mar;47(3):750-5. Resumo
58. van der Jagt M, Hasan D, Bijvoet HW, et al. Validity of prediction of the site of ruptured intracranial aneurysms with CT. Neurology. 1999 Jan 1;52(1):34-9. Resumo
59. Cruickshank A, Auld P, Beetham R, et al; UK NEQAS Specialist Advisory Group for EQA of CSF Proteins and Biochemistry. Revised national guidelines for analysis of cerebrospinal fluid for bilirubin in suspected subarachnoid haemorrhage. Ann Clin Biochem. 2008 May;45(Pt 3):238-44.Texto completo Resumo
60. Wijdicks EF, Kallmes DF, Manno EM, et al. Subarachnoid hemorrhage: neurointensive care and aneurysm repair. Mayo Clin Proc. 2005 Apr;80(4):550-9. Resumo
61. Lavi R, Yarnitsky D, Rowe JM, et al. Standard vs atraumatic Whitacre needle for diagnostic lumbar puncture: a randomized trial. Neurology. 2006 Oct 24;67(8):1492-4. Resumo
62. Arendt K, Demaerschalk BM, Wingerchuk DM, et al. Atraumatic lumbar puncture needles: after all these years, are we still missing the point? Neurologist. 2009 Jan;15(1):17-20. Resumo
63. Nath S, Koziarz A, Badhiwala JH, et al. Atraumatic versus conventional lumbar puncture needles: a systematic review and meta-analysis. Lancet. 2018 Mar 24;391(10126):1197-204. Resumo
64. Rochwerg B, Almenawer SA, Siemieniuk RAC, et al. Atraumatic (pencil-point) versus conventional needles for lumbar puncture: a clinical practice guideline. BMJ. 2018 May 22;361:k1920.Texto completo
65. Ahmed SV, Jayawarna C, Jude E. Post lumbar puncture headache: diagnosis and management. Postgrad Med J. 2006 Nov;82(973):713-6.Texto completo Resumo
66. Arevalo-Rodriguez I, Ciapponi A, Roqué i Figuls M, et al. Posture and fluids for preventing post-dural puncture headache. Cochrane Database Syst Rev. 2016 Mar 7;(3):CD009199.Texto completo Resumo
67. American College of Radiology. ACR Appropriateness Criteria®: cerebrovascular diseases - aneurysm, vascular malformation, and subarachnoid hemorrhage. 2021 [internet publication].Texto completo Resumo
68. Chappell ET, Moure FC, Good MC. Comparison of computed tomographic angiography with digital subtraction angiography in the diagnosis of cerebral aneurysms: a meta-analysis. Neurosurgery. 2003 Mar;52(3):624-31. Resumo
69. Hoh BL, Cheung AC, Rabinov JD, et al. Results of a prospective protocol of computed tomographic angiography in place of catheter angiography as the only diagnostic and pretreatment planning study for cerebral aneurysms by a combined neurovascular team. Neurosurgery. 2004 Jun;54(6):1329-40. Resumo
70. Jayaraman MV, Mayo-Smith WW, Tung GA, et al. Detection of intracranial aneurysms: multi-detector row CT angiography compared with DSA. Radiology. 2004 Feb;230(2):510-8. Resumo
71. Kouskouras C, Charitanti A, Giavroglou C, et al. Intracranial aneurysms: evaluation using CTA and MRA. Correlation with DSA and intraoperative findings. Neuroradiology. 2004 Oct;46(10):842-50. Resumo
72. van Gelder JM. Computed tomographic angiography for detecting cerebral aneurysms: implications of aneurysm size distribution for the sensitivity, specificity, and likelihood ratios. Neurosurgery. 2003 Sep;53(3):597-605. Resumo
73. Menke J, Larsen J, Kallenberg K. Diagnosing cerebral aneurysms by computed tomographic angiography: meta-analysis. Ann Neurol. 2011 Apr;69(4):646-54. Resumo
74. Agid R, Andersson T, Almqvist H, et al. Negative CT angiography findings in patients with spontaneous subarachnoid hemorrhage: When is digital subtraction angiography still needed? AJNR Am J Neuroradiol. 2010 Apr;31(4):696-705.Texto completo Resumo
75. Sailer AM, Wagemans BA, Nelemans PJ, et al. Diagnosing intracranial aneurysms with MR angiography: systematic review and meta-analysis. Stroke. 2014 Jan;45(1):119-26. Resumo
76. Catapano JS, Lang MJ, Koester SW, et al. Digital subtraction cerebral angiography after negative computed tomography angiography findings in non-traumatic subarachnoid hemorrhage. J Neurointerv Surg. 2020 May;12(5):526-30.Texto completo Resumo
77. Heit JJ, Pastena GT, Nogueira RG, et al. Cerebral angiography for evaluation of patients with CT angiogram-negative subarachnoid hemorrhage: an 11-year experience. AJNR Am J Neuroradiol. 2016 Feb;37(2):297-304.Texto completo Resumo
78. Howard BM, Hu R, Barrow JW, et al. Comprehensive review of imaging of intracranial aneurysms and angiographically negative subarachnoid hemorrhage. Neurosurg Focus. 2019 Dec 1;47(6):E20.Texto completo Resumo
79. Rustemi O, Alaraj A, Shakur SF, et al. Detection of unruptured intracranial aneurysms on noninvasive imaging. Is there still a role for digital subtraction angiography? Surg Neurol Int. 2015;6:175.Texto completo Resumo
80. de Rooij NK, Linn FH, van der Plas JA, et al. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry. 2007 Dec;78(12):1365-72. Resumo
81. Xia C, Hoffman H, Anikpezie N, et al. Trends in the incidence of spontaneous subarachnoid hemorrhages in the United States, 2007-2017. Neurology. 2023 Jan;100(2):e123-32. Resumo
82. Macdonald RL, Schweizer TA. Spontaneous subarachnoid haemorrhage. Lancet. 2017 Feb;389(10069):655-66. Resumo
83. Perry JJ, Sivilotti MLA, Sutherland J, et al. Validation of the Ottawa subarachnoid hemorrhage rule in patients with acute headache. CMAJ. 2017 Nov;189(45):E1379-85.Texto completo Resumo
84. Green DM, Burns JD, DeFusco CM. ICU management of aneurysmal subarachnoid hemorrhage. J Intensive Care Med. 2013 Nov-Dec;28(6):341-54. Resumo
85. Behrouz R, Birnbaum LA, Jones PM, et al. Focal neurological deficit at onset of aneurysmal subarachnoid hemorrhage: frequency and causes. J Stroke Cerebrovasc Dis. 2016 Nov;25(11):2644-7. Resumo
86. Panczykowski D, Pease M, Zhao Y, et al. Prophylactic antiepileptics and seizure incidence following subarachnoid hemorrhage: a propensity score-matched analysis. Stroke. 2016 Jul;47(7):1754-60.Texto completo Resumo
87. Chumnanvej S, Dunn IF, Kim DH. Three-day phenytoin prophylaxis is adequate after subarachnoid hemorrhage. Neurosurgery. 2007 Jan;60(1):99-102; discussion 102-3.Texto completo Resumo
88. Rosengart AJ, Huo JD, Tolentino J, et al. Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs. J Neurosurg. 2007 Aug;107(2):253-60. Resumo
89. McGirt MJ, Mavropoulos JC, McGirt LY, et al. Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003 Jun;98(6):1222-6. Resumo
90. de Oliveira Manoel AL, Goffi A, Marotta TR, et al. The critical care management of poor-grade subarachnoid haemorrhage. Crit Care. 2016 Jan 23;20:21.Texto completo Resumo
91. Sherlock M, O'Sullivan E, Agha A, et al. The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage. Clin Endocrinol (Oxf). 2006 Mar;64(3):250-4. Resumo
92. Zhang L, Wang Z, Qi S. Cardiac troponin elevation and outcome after subarachnoid hemorrhage: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2015 Oct;24(10):2375-84. Resumo
93. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968 Jan;28(1):14-20.
94. Frontera JA, Claassen J, Schmidt JM, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery. 2006 Jul;59(1):21-7; discussion 21-7. Resumo
95. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980 Jan;6(1):1-9. Resumo
96. Diringer MN. Management of aneurysmal subarachnoid hemorrhage. Crit Care Med. 2009 Feb;37(2):432-40. Resumo
97. Diringer MN, Bleck TP, Claude Hemphill J 3rd, et al; Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care. 2011 Sep;15(2):211-40. Resumo
98. Soar J, Böttiger BW, Carli P, et al. European Resuscitation Council Guidelines 2021: adult advanced life support. Resuscitation. 2021 Apr;161:115-51.Texto completo Resumo
99. Colquhoun MC, Handley AJ, Evans TR, eds. ABC of resuscitation. 5th ed. Wiley-Blackwell; 2004.
100. Chrimes N, Higgs A, Hagberg CA, et al. Preventing unrecognised oesophageal intubation: a consensus guideline from the Project for Universal Management of Airways and international airway societies. Anaesthesia. 2022 Aug 17 [Epub ahead of print].Texto completo Resumo
101. Ascanio LC, Enriquez-Marulanda A, Maragkos GA, et al. Effect of blood pressure variability during the acute period of subarachnoid hemorrhage on functional outcomes. Neurosurgery. 2020 Sep;87(4):779-87. Resumo
102. Greenberg SM, Ziai WC, Cordonnier C, et al. 2022 Guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke. 2022 Jul;53(7):e282-361.Texto completo
103. Mutoh T, Kazumata K, Terasaka S, et al. Early intensive versus minimally invasive approach to postoperative hemodynamic management after subarachnoid hemorrhage. Stroke. 2014 May;45(5):1280-4. Resumo
104. Chui J, Craen R, Dy-Valdez C, et al. Early goal-directed therapy during endovascular coiling procedures following aneurysmal subarachnoid Hhemorrhage: a pilot prospective randomized controlled study. J Neurosurg Anesthesiol. 2022 Jan;34(1):35-43. Resumo
105. Hoff R, Rinkel G, Verweij B, et al. Blood volume measurement to guide fluid therapy after aneurysmal subarachnoid hemorrhage: a prospective controlled study. Stroke. 2009 Jul;40(7):2575-7.Texto completo Resumo
106. Tagami T, Kuwamoto K, Watanabe A, et al. Effect of triple-h prophylaxis on global end-diastolic volume and clinical outcomes in patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2014 Dec;21(3):462-9. Resumo
107. Lennihan L, Mayer SA, Fink ME, et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2000 Feb;31(2):383-91. Resumo
108. Rinkel GJ, Feigin VL, Algra A, et al. Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD000483.Texto completo Resumo
109. Wartenberg KE, Parra A. CT and CT-perfusion findings of reversible leukoencephalopathy during triple-H therapy for symptomatic subarachnoid hemorrhage-related vasospasm. J Neuroimaging. 2006 Apr;16(2):170-5. Resumo
110. Nakagawa I, Hironaka Y, Nishimura F, et al. Early inhibition of natriuresis suppresses symptomatic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Cerebrovasc Dis. 2013;35(2):131-7.Texto completo Resumo
111. Mori T, Katayama Y, Kawamata T, et al. Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 1999 Dec;91(6):947-52. Resumo
112. Mistry AM, Mistry EA, Ganesh Kumar N, et al. Corticosteroids in the management of hyponatremia, hypovolemia, and vasospasm in subarachnoid hemorrhage: a meta-analysis. Cerebrovasc Dis. 2016;42(3-4):263-71.Texto completo Resumo
113. Treggiari MM, Rabinstein AA, Busl KM, et al. Guidelines for the neurocritical care management of aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2023 Aug;39(1):1-28. Resumo
114. Marigold R, Günther A, Tiwari D, et al. Antiepileptic drugs for the primary and secondary prevention of seizures after subarachnoid haemorrhage. Cochrane Database Syst Rev. 2013 Jun 5;(6):CD008710.Texto completo Resumo
115. Feng R, Mascitelli J, Chartrain AG, et al. Anti-epileptic drug (AED) use in subarachnoid hemorrhage (SAH) and intracranial hemorrhage (ICH). Curr Pharm Des. 2017;23(42):6446-53. Resumo
116. Naidech AM, Kreiter KT, Janjua N, et al. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke. 2005 Mar;36(3):583-7.Texto completo Resumo
117. Kodankandath TV, Farooq S, Wazni W, et al. Seizure prophylaxis in the immediate post-hemorrhagic period in patients with aneurysmal subarachnoid hemorrhage. J Vasc Interv Neurol. 2017 Dec;9(6):1-4.Texto completo Resumo
118. Dewan MC, Mocco J. Current practice regarding seizure prophylaxis in aneurysmal subarachnoid hemorrhage across academic centers. J Neurointerv Surg. 2015 Feb;7(2):146-9.Texto completo Resumo
119. Szaflarski JP, Sangha KS, Lindsell CJ, et al. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. Neurocrit Care. 2010 Apr;12(2):165-72. Resumo
120. Suarez JI, Zaidat OO, Suri MF, et al. Length of stay and mortality in neurocritically ill patients: impact of a specialized neurocritical care team. Crit Care Med. 2004 Nov;32(11):2311-7. Resumo
121. Broderick JP, Brott TG, Duldner JE, et al. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke. 1994 Jul;25(7):1342-7. Resumo
122. Food and Drug Administration. FDA drug safety communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. Jan 2018 [internet publication].Texto completo
123. Johnston SC, Dowd CF, Higashida RT, et al. Predictors of rehemorrhage after treatment of ruptured intracranial aneurysms: the cerebral aneurysm rerupture after treatment (CARAT) study. Stroke. 2008 Jan;39(1):120-5.Texto completo Resumo
124. Pierot L, Barbe C, Herbreteau D, et al. Rebleeding and bleeding in the year following intracranial aneurysm coiling: analysis of a large prospective multicenter cohort of 1140 patients-analysis of recanalization after endovascular treatment of intracranial aneurysm (ARETA) Study. J Neurointerv Surg. 2020 Dec;12(12):1219-25. Resumo
125. Campi A, Ramzi N, Molyneux AJ, et al. Retreatment of ruptured cerebral aneurysms in patients randomized by coiling or clipping in the international subarachnoid aneurysm trial (ISAT). Stroke. 2007 May;38(5):1538-44.Texto completo Resumo
126. Dorhout Mees SM, Molyneux AJ, Kerr RS, et al. Timing of aneurysm treatment after subarachnoid hemorrhage: relationship with delayed cerebral ischemia and poor outcome. Stroke. 2012 Aug;43(8):2126-9. Resumo
127. Diringer MN. To clip or to coil acutely ruptured intracranial aneurysms: update on the debate. Curr Opin Crit Care. 2005 Apr;11(2):121-5. Resumo
128. Molyneux A, Kerr R, Stratton I, et al; International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002 Oct 26;360(9342):1267-74. Resumo
129. Molyneux AJ, Kerr RS, Yu LM, et al; International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 2005 Sep 3-9;366(9488):809-17. Resumo
130. Molyneux AJ, Kerr RS, Birks J, et al; ISAT Collaborators. Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up. Lancet Neurol. 2009 May;8(5):427-33.Texto completo Resumo
131. Molyneux AJ, Birks J, Clarke A, et al. The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms: 18 year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT). Lancet. 2015 Feb 21;385(9969):691-7.Texto completo Resumo
132. National Institute for Health and Care Excellence. Pipeline embolisation device for the treatment of complex intracranial aneurysms. January 2019 [internet publication].Texto completo
133. Henkes H, Fischer S, Weber W, et al. Endovascular coil occlusion of 1811 intracranial aneurysms: early angiographic and clinical results. Neurosurgery. 2004 Feb;54(2):268-80. Resumo
134. Lozier AP, Connolly ES Jr, Lavine SD, et al. Guglielmi detachable coil embolization of posterior circulation aneurysms: a systematic review of the literature. Stroke. 2002 Oct;33(10):2509-18. Resumo
135. Murayama Y, Nien YL, Duckwiler G, et al. Guglielmi detachable coil embolization of cerebral aneurysms: 11 years' experience. J Neurosurg. 2003 May;98(5):959-66. Resumo
136. Raymond J, Guilbert F, Weill A, et al. Long-term angiographic recurrences after selective endovascular treatment of aneurysms with detachable coils. Stroke. 2003 Jun;34(6):1398-403.Texto completo Resumo
137. Li H, Pan R, Wang H, et al. Clipping versus coiling for ruptured intracranial aneurysms: a systematic review and meta-analysis. Stroke. 2013 Jan;44(1):29-37.Texto completo Resumo
138. Lindgren A, Vergouwen MD, van der Schaaf I, et al. Endovascular coiling versus neurosurgical clipping for people with aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2018 Aug;8(8):CD003085.Texto completo Resumo
139. Spetzler RF, McDougall CG, Albuquerque FC, et al. The barrow ruptured aneurysm trial: 3-year results. J Neurosurg. 2013 Jul;119(1):146-57.Texto completo Resumo
140. Spetzler RF, McDougall CG, Zabramski JM, et al. The barrow ruptured aneurysm trial: 6-year results. J Neurosurg. 2015 Sep;123(3):609-17.Texto completo Resumo
141. Mitchell P, Kerr R, Mendelow AD, et al. Could late rebleeding overturn the superiority of cranial aneurysm coil embolization over clip ligation seen in the international subarachnoid aneurysm trial? J Neurosurg. 2008 Mar;108(3):437-42. Resumo
142. Ryttlefors M, Enblad P, Kerr RS, et al. International subarachnoid aneurysm trial of neurosurgical clipping versus endovascular coiling: subgroup analysis of 278 elderly patients. Stroke. 2008 Oct;39(10):2720-6.Texto completo Resumo
143. Liu J, Chen Q. Effect of statins treatment for patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of observational studies and randomized controlled trials. Int J Clin Exp Med. 2015 May 15;8(5):7198-208.Texto completo Resumo
144. Dorhout Mees SM, Algra A, Vandertop WP, et al; MASH-2 Study Group. Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Lancet. 2012 Jul 7;380(9836):44-9.Texto completo Resumo
145. Ma J, Huang S, Ma L, et al. Endothelin-receptor antagonists for aneurysmal subarachnoid hemorrhage: an updated meta-analysis of randomized controlled trials. Crit Care. 2012 Oct 18;16(5):R198.Texto completo Resumo
146. Shen J, Shen J, Zhu K, et al. Efficacy of statins in cerebral vasospasm, mortality, and delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of randomized controlled trials. World Neurosurg. 2019 Nov;131:e65-e73.Texto completo Resumo
147. Pontes JPM, Santos MDC, Gibram FC, et al. Efficacy and safety of clazosentan after aneurysmal subarachnoid hemorrhage: an updated meta-analysis. Neurosurgery. 2023 Dec 1;93(6):1208-19. Resumo
148. Endo H, Hagihara Y, Kimura N, et al. Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients. J Neurosurg. 2022 Dec 1;137(6):1707-17.Texto completo Resumo
149. Nieuwkamp DJ, Setz LE, Algra A, et al. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol. 2009 Jul;8(7):635-42. Resumo
150. Mackey J, Khoury JC, Alwell K, et al. Stable incidence but declining case-fatality rates of subarachnoid hemorrhage in a population. Neurology. 2016 Nov 22;87(21):2192-7.Texto completo Resumo
151. Lovelock CE, Rinkel GJ, Rothwell PM. Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review. Neurology. 2010 May 11;74(19):1494-501.Texto completo Resumo
152. Hop JW, Rinkel GJ, Algra A, et al. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke. 1997 Mar;28(3):660-4. Resumo
153. Dijkland SA, Roozenbeek B, Brouwer PA, et al. Prediction of 60-day case fatality after aneurysmal subarachnoid hemorrhage: external validation of a prediction model. Crit Care Med. 2016 Aug;44(8):1523-9. Resumo
154. Johnston SC, Selvin S, Gress DR. The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology. 1998 May;50(5):1413-8. Resumo
155. Abulhasan YB, Alabdulraheem N, Simoneau G, et al. Mortality after spontaneous subarachnoid hemorrhage: causality and validation of a prediction model. World Neurosurg. 2018 Apr;112:e799-e811.Texto completo Resumo
156. Mahaney KB, Todd MM, Bayman EO, et al; IHAST Investigators. Acute postoperative neurological deterioration associated with surgery for ruptured intracranial aneurysm: incidence, predictors, and outcomes. J Neurosurg. 2012 Jun;116(6):1267-78. Resumo
157. Diringer MN. Subarachnoid hemorrhage: a multiple-organ system disease. Crit Care Med. 2003 Jun;31(6):1884-5.
158. van der Bilt I, Hasan D, van den Brink R, et al; SEASAH (Serial Echocardiography After Subarachnoid Hemorrhage) Investigators. Cardiac dysfunction after aneurysmal subarachnoid hemorrhage: relationship with outcome. Neurology. 2014 Jan 28;82(4):351-8. Resumo
159. PROMOTE-SAH Investigators. Six-month mortality and functional outcomes in aneurysmal sub-arachnoid haemorrhage patients admitted to intensive care units in Australia and New Zealand: a prospective cohort study. J Clin Neurosci. 2020 Oct;80:92-9. Resumo
160. Hackett ML, Anderson CS. Health outcomes 1 year after subarachnoid hemorrhage: an international population-based study. The Australian Cooperative Research on Subarachnoid Hemorrhage Study Group. Neurology. 2000 Sep 12;55(5):658-62. Resumo
161. Mayer SA, Kreiter KT, Copeland D, et al. Global and domain-specific cognitive impairment and outcome after subarachnoid hemorrhage. Neurology. 2002 Dec 10;59(11):1750-8. Resumo
162. Buczacki SJ, Kirkpatrick PJ, Seeley HM, et al. Late epilepsy following open surgery for aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2004 Nov;75(11):1620-2.Texto completo Resumo
163. Scott RB, Eccles F, Molyneux AJ, et al. Improved cognitive outcomes with endovascular coiling of ruptured intracranial aneurysms: neuropsychological outcomes from the International Subarachnoid Aneurysm Trial (ISAT). Stroke. 2010 Aug;41(8):1743-7.Texto completo Resumo
164. Gruber A, Reinprecht A, Illievich UM, et al. Extracerebral organ dysfunction and neurologic outcome after aneurysmal subarachnoid hemorrhage. Crit Care Med. 1999 Mar;27(3):505-14. Resumo
165. Kochanek PM, Yonas H. Subarachnoid hemorrhage, systemic immune response syndrome, and MODS: is there cross-talk between the injured brain and the extra-cerebral organ systems? Multiple organ dysfunction syndrome. Crit Care Med. 1999 Mar;27(3):454-5.
166. Berman MF, Solomon RA, Mayer SA, et al. Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. Stroke. 2003 Sep;34(9):2200-7. Resumo
167. Johnston SC. Effect of endovascular services and hospital volume on cerebral aneurysm treatment outcomes. Stroke. 2000 Jan;31(1):111-7. Resumo
168. Solomon RA, Mayer SA, Tarmey JJ. Relationship between the volume of craniotomies for cerebral aneurysm performed at New York state hospitals and in-hospital mortality. Stroke. 1996 Jan;27(1):13-7. Resumo
169. Bardach NS, Olson SJ, Elkins JS, et al. Regionalization of treatment for subarachnoid hemorrhage: a cost-utility analysis. Circulation. 2004 May 11;109(18):2207-12. Resumo
170. Chen Y, Xia F, Cai C, et al. Duration and choices of prophylactic anticonvulsants in subarachnoid hemorrhage: a systematic review and meta-analysis. Neurosurg Rev. 2021 Oct;44(5):2459-67.Texto completo Resumo
171. Raper DM, Starke RM, Komotar RJ, et al. Seizures after aneurysmal subarachnoid hemorrhage: a systematic review of outcomes. World Neurosurg. 2013 May-Jun;79(5-6):682-90.Texto completo Resumo
172. Claassen J, Peery S, Kreiter KT, et al. Predictors and clinical impact of epilepsy after subarachnoid hemorrhage. Neurology. 2003 Jan 28;60(2):208-14. Resumo
173. Huttunen J, Kurki MI, von Und Zu Fraunberg M, et al. Epilepsy after aneurysmal subarachnoid hemorrhage: a population-based, long-term follow-up study. Neurology. 2015 Jun 2;84(22):2229-37. Resumo
174. Claassen J, Mayer SA, Kowalski RG, et al. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology. 2004 May 25;62(10):1743-8. Resumo
175. van Donkelaar CE, Bakker NA, Veeger NJ, et al. Predictive factors for rebleeding after aneurysmal subarachnoid hemorrhage: rebleeding aneurysmal subarachnoid hemorrhage study. Stroke. 2015 Aug;46(8):2100-6. Resumo
176. Adams HP Jr, Kassell NF, Torner JC, et al. Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhage: influences of clinical condition, CT results, and antifibrinolytic therapy. A report of the Cooperative Aneurysm Study. Neurology. 1987 Oct;37(10):1586-91. Resumo
177. Post R, Germans MR, Tjerkstra MA, et al. Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial. Lancet. 2021 Jan 9;397(10269):112-8.Texto completo Resumo
178. Germans MR, Dronkers WJ, Baharoglu MI, et al. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2022 Nov;11(11):CD001245.Texto completo Resumo
179. Shi M, Yang C, Chen ZH, et al. Efficacy and safety of tranexamic acid in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of randomized controlled trials. Front Surg. 2021;8:790149.Texto completo Resumo
180. van Gijn J, Hijdra A, Wijdicks EF, et al. Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurosurg. 1985 Sep;63(3):355-62. Resumo
181. Hijdra A, van Gijn J, Nagelkerke NJ, et al. Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. Stroke. 1988 Oct;19(10):1250-6. Resumo
182. Chung DY, Olson DM, John S, et al. Evidence-based management of external ventricular drains. Curr Neurol Neurosci Rep. 2019 Nov 26;19(12):94.Texto completo Resumo
183. Komotar RJ, Hahn DK, Kim GH, et al. Efficacy of lamina terminalis fenestration in reducing shunt-dependent hydrocephalus following aneurysmal subarachnoid hemorrhage: a systematic review. Clinical article. J Neurosurg. 2009 Jul;111(1):147-54. Resumo
184. Gruber A, Reinprecht A, Bavinzski G, et al. Chronic shunt-dependent hydrocephalus after early surgical and early endovascular treatment of ruptured intracranial aneurysms. Neurosurgery. 1999 Mar;44(3):503-9. Resumo
185. Etminan N, Vergouwen MD, Ilodigwe D, et al. Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab. 2011 Jun;31(6):1443-51.Texto completo Resumo
186. Sampson TR, Dhar R, Diringer MN. Factors associated with the development of anemia after subarachnoid hemorrhage. Neurocrit Care. 2010 Feb;12(1):4-9.Texto completo Resumo
187. Naidech AM, Jovanovic B, Wartenberg KE, et al. Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage. Crit Care Med. 2007 Oct;35(10):2383-9. Resumo
188. Naidech AM, Drescher J, Ault ML, et al. Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage. Neurosurgery. 2006 Oct;59(4):775-9. Resumo
189. Kramer AH, Zygun DA, Bleck TP, et al. Relationship between hemoglobin concentrations and outcomes across subgroups of patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2009;10(2):157-65. Resumo
190. Dhar R, Zazulia AR, Videen TO, et al. Red blood cell transfusion increases cerebral oxygen delivery in anemic patients with subarachnoid hemorrhage. Stroke. 2009 Sep;40(9):3039-44.Texto completo Resumo
191. Keyrouz SG, Diringer MN. Clinical review: prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care. 2007;11(4):220. Resumo
192. Mayberg MR. Cerebral vasospasm. Neurosurg Clin N Am. 1998 Jul;9(3):615-27. Resumo
193. Pradilla G, Chaichana KL, Hoang S, et al. Inflammation and cerebral vasospasm after subarachnoid hemorrhage. Neurosurg Clin N Am. 2010 Apr;21(2):365-79. Resumo
194. Miller JA, Dacey RG Jr, Diringer MN. Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage. Stroke. 1995 Dec;26(12):2260-6. Resumo
195. Budohoski KP, Guilfoyle M, Helmy A, et al. The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1343-53.Texto completo Resumo
196. Claassen J, Bernardini GL, Kreiter K, et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher Scale revisited. Stroke. 2001 Sep;32(9):2012-20. Resumo
197. Hop JW, Rinkel GJ, Algra A, et al. Initial loss of consciousness and risk of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke. 1999 Nov;30(11):2268-71. Resumo
198. de Rooij NK, Greving JP, Rinkel GJ, et al. Early prediction of delayed cerebral ischemia after subarachnoid hemorrhage: development and validation of a practical risk chart. Stroke. 2013 May;44(5):1288-94. Resumo
199. de Oliveira JG, Beck J, Ulrich C, et al. Comparison between clipping and coiling on the incidence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurosurg Rev. 2007 Jan;30(1):22-30. Resumo
200. van den Bergh WM, Kerr RS, Algra A, et al; International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. Effect of antiplatelet therapy for endovascular coiling in aneurysmal subarachnoid hemorrhage. Stroke. 2009 Jun;40(6):1969-72.Texto completo Resumo
201. Lad SP, Guzman R, Kelly ME, et al. Cerebral perfusion imaging in vasospasm. Neurosurg Focus. 2006 Sep 15;21(3):E7. Resumo
202. Greenberg ED, Gold R, Reichman M, et al. Diagnostic accuracy of CT angiography and CT perfusion for cerebral vasospasm: a meta-analysis. AJNR Am J Neuroradiol. 2010 Nov;31(10):1853-60.Texto completo Resumo
203. Ionita CC, Graffagnino C, Alexander MJ, et al. The value of CT angiography and transcranial doppler sonography in triaging suspected cerebral vasospasm in SAH prior to endovascular therapy. Neurocrit Care. 2008;9(1):8-12. Resumo
204. Shankar JJ, Tan IY, Krings T, et al. CT angiography for evaluation of cerebral vasospasm following acute subarachnoid haemorrhage. Neuroradiology. 2012 Mar;54(3):197-203. Resumo
205. Manno EM, Gress DR, Schwamm LH, et al. Effects of induced hypertension on transcranial Doppler ultrasound velocities in patients after subarachnoid hemorrhage. Stroke. 1998 Feb;29(2):422-8. Resumo
206. Rigamonti A, Ackery A, Baker AJ. Transcranial Doppler monitoring in subarachnoid hemorrhage: a critical tool in critical care. Can J Anaesth. 2008 Feb;55(2):112-23. Resumo
207. Chen HY, Elmer J, Zafar SF, et al. Combining transcranial Doppler and EEG data to predict delayed cerebral ischemia after subarachnoid hemorrhage. Neurology. 2022 Feb;98(5):e459-69. Resumo
208. Chang JJ, Triano M, Corbin MJ, et al. Transcranial Doppler velocity and associations with delayed cerebral ischemia in aneurysmal subarachnoid Hemorrhage. J Neurol Sci. 2020 Aug 15;415:116934. Resumo
209. Rosenthal ES, Biswal S, Zafar SF, et al. Continuous electroencephalography predicts delayed cerebral ischemia after subarachnoid hemorrhage: A prospective study of diagnostic accuracy. Ann Neurol. 2018 May;83(5):958-69.Texto completo Resumo
210. Gathier CS, van den Bergh WM, van der Jagt M, et al. Induced hypertension for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a randomized clinical trial. Stroke. 2018 Jan;49(1):76-83.Texto completo Resumo
211. Gathier CS, Dankbaar JW, van der Jagt M, et al. Effects of induced hypertension on cerebral perfusion in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a randomized clinical trial. Stroke. 2015 Nov;46(11):3277-81.Texto completo Resumo
212. Muhammad S, Güresir Á, Greschus S, et al. Posterior reversible encephalopathy syndrome as an overlooked complication of induced hypertension for cerebral vasospasm: systematic review and illustrative case. Stroke. 2016 Feb;47(2):519-22.Texto completo Resumo
213. Dankbaar JW, Slooter AJ, Rinkel GJ, et al. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit Care. 2010;14(1):R23.Texto completo Resumo
214. Mindea SA, Yang BP, Bendok BR, et al. Endovascular treatment strategies for cerebral vasospasm. Neurosurg Focus. 2006 Sep 15;21(3):E13. Resumo
215. Polin RS, Coenen VA, Hansen CA, et al. Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2000 Feb;92(2):284-90. Resumo
216. Rosenwasser RH, Armonda RA, Thomas JE, et al. Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. Neurosurgery. 1999 May;44(5):975-9. Resumo
217. Rabinstein AA, Friedman JA, Nichols DA, et al. Predictors of outcome after endovascular treatment of cerebral vasospasm. AJNR Am J Neuroradiol. 2004 Nov-Dec;25(10):1778-82. Resumo
218. Barker FG 2nd, Ogilvy CS. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg. 1996 Mar;84(3):405-14. Resumo
219. Dorhout Mees SM, Rinkel GJ, Feigin VL, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD000277.Texto completo Resumo
220. Feigin VL, Anderson N, Rinkel GJ, et al. Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004583. Resumo
221. Haley EC Jr, Kassell NF, Apperson-Hansen C, et al. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. J Neurosurg. 1997 Mar;86(3):467-74. Resumo
222. Kassell NF, Haley EC Jr, Apperson-Hansen C, et al. Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. J Neurosurg. 1996 Feb;84(2):221-8. Resumo
223. Lanzino G, Kassell NF. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America. J Neurosurg. 1999 Jun;90(6):1018-24. Resumo
224. Lanzino G, Kassell NF, Dorsch NW, et al. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa. J Neurosurg. 1999 Jun;90(6):1011-7. Resumo
225. Zhang S, Wang L, Liu M, Wu B. Tirilazad for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2010 Feb 17;(2):CD006778.Texto completo Resumo
226. Lynch JR, Wang H, McGirt MJ, et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke. 2005 Sep;36(9):2024-6. Resumo
227. Tseng MY, Czosnyka M, Richards H, et al. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke. 2005 Aug;36(8):1627-32. Resumo
228. Chou SH, Smith EE, Badjatia N, et al. A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage. Stroke. 2008 Oct;39(10):2891-3.Texto completo Resumo
229. Vergouwen MD, Meijers JC, Geskus RB, et al. Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial. J Cereb Blood Flow Metab. 2009 Aug;29(8):1444-53. Resumo
230. Dorhout Mees SM, van den Bergh WM, Algra A, et al. Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD006184.Texto completo Resumo
231. Post R, Tjerkstra MA, Middeldorp S, et al. Platelet transfusion in patients with aneurysmal subarachnoid hemorrhage is associated with poor clinical outcome. Sci Rep. 2020 Jan 21;10(1):856.Texto completo Resumo
232. Kasuya H, Onda H, Takeshita M, et al. Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans. Stroke. 2002 Apr;33(4):1011-5.Texto completo Resumo
233. Kasuya H, Onda H, Sasahara A, et al. Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery. 2005 May;56(5):895-902. Resumo
234. Barth M, Capelle HH, Weidauer S, et al. Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study. Stroke. 2007 Feb;38(2):330-6.Texto completo Resumo
235. Dodson V, Majmundar N, El-Ghanem M, et al. Intracranial administration of nicardipine after aneurysmal subarachnoid hemorrhage: a review of the literature. World Neurosurg. 2019 May;125:511-518.e1.Texto completo Resumo
236. Omeis I, Neil JA, Murali R, Abrahams JM. Treatment of cerebral vasospasm with biocompatible controlled-release systems for intracranial drug delivery. Neurosurgery. 2008 Dec;63(6):1011-9. Resumo
237. Smith WS, Dowd CF, Johnston SC, et al. Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2004 Nov;35(11):2518-22.Texto completo Resumo
238. Kramer AH, Fletcher JJ. Locally-administered intrathecal thrombolytics following aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurocrit Care. 2011 Jun;14(3):489-99. Resumo
239. Lee KS, Chari A, Motiwala M, et al. Effectiveness of cerebrospinal fluid lumbar drainage among patients with aneurysmal subarachnoid hemorrhage: an updated systematic review and meta-Analysis. World Neurosurg. 2024 Mar;183:246-53.e12. Resumo
240. Nolan CP, Macdonald RL. Can angiographic vasospasm be used as a surrogate marker in evaluating therapeutic interventions for cerebral vasospasm? Neurosurg Focus. 2006 Sep 15;21(3):E1. Resumo
241. Suarez JI, Shannon L, Zaidat OO, et al. Effect of human albumin administration on clinical outcome and hospital cost in patients with subarachnoid hemorrhage. J Neurosurg. 2004 Apr;100(4):585-90. Resumo
242. Deibert E, Aiyagari V, Diringer MN. Reversible left ventricular dysfunction associated with raised troponin I after subarachnoid haemorrhage does not preclude successful heart transplantation. Heart. 2000 Aug;84(2):205-7. Resumo
243. Khush K, Kopelnik A, Tung P, et al. Age and aneurysm position predict patterns of left ventricular dysfunction after subarachnoid hemorrhage. J Am Soc Echocardiogr. 2005 Feb;18(2):168-74. Resumo
244. Dorhout Mees SM, van Dijk GW, Algra A, et al. Glucose levels and outcome after subarachnoid hemorrhage. Neurology. 2003 Oct 28;61(8):1132-3. Resumo
245. Juvela S, Siironen J, Kuhmonen J. Hyperglycemia, excess weight, and history of hypertension as risk factors for poor outcome and cerebral infarction after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2005 Jun;102(6):998-1003. Resumo
246. Claassen J, Vu A, Kreiter KT, et al. Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage. Crit Care Med. 2004 Mar;32(3):832-8. Resumo
247. Kruyt ND, Biessels GJ, de Haan RJ, et al. Hyperglycemia and clinical outcome in aneurysmal subarachnoid hemorrhage: a meta-analysis. Stroke. 2009 Jun;40(6):e424-30. Resumo
248. Pasternak JJ, McGregor DG, Schroeder DR, et al. Hyperglycemia in patients undergoing cerebral aneurysm surgery: its association with long-term gross neurologic and neuropsychological function. Mayo Clin Proc. 2008 Apr;83(4):406-17.Texto completo Resumo
249. Lanzino G. Plasma glucose levels and outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2005 Jun;102(6):974-5; discussion 975-6.
250. Lee SH, Lim JS, Kim N, et al. Effects of admission glucose level on mortality after subarachnoid hemorrhage: a comparison between short-term and long-term mortality. J Neurol Sci. 2008 Dec 15;275(1-2):18-21.Texto completo Resumo
251. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006 Feb 2;354(5):449-61.Texto completo Resumo
252. Diringer MN, Reaven NL, Funk SE, et al. Elevated body temperature independently contributes to increased length of stay in neurologic intensive care unit patients. Crit Care Med. 2004 Jul;32(7):1489-95. Resumo
253. Commichau C, Scarmeas N, Mayer SA. Risk factors for fever in the neurologic intensive care unit. Neurology. 2003 Mar 11;60(5):837-41. Resumo
254. Todd MM, Hindman BJ, Clarke WR, et al; IHAST Investigators. Perioperative fever and outcome in surgical patients with aneurysmal subarachnoid hemorrhage. Neurosurgery. 2009 May;64(5):897-908. Resumo
255. Broessner G, Beer R, Lackner P, et al. Prophylactic, endovascularly based, long-term normothermia in ICU patients with severe cerebrovascular disease: bicenter prospective, randomized trial. Stroke. 2009 Dec;40(12):e657-65.Texto completo Resumo
256. Mayer SA, Kowalski RG, Presciutti M, et al. Clinical trial of a novel surface cooling system for fever control in neurocritical care patients. Crit Care Med. 2004 Dec;32(12):2508-15. Resumo
257. Lavinio A, Andrzejowski J, Antonopoulou I, et al. Targeted temperature management in patients with intracerebral haemorrhage, subarachnoid haemorrhage, or acute ischaemic stroke: updated consensus guideline recommendations by the Neuroprotective Therapy Consensus Review (NTCR) group. Br J Anaesth. 2023 Aug;131(2):294-301.Texto completo Resumo
258. Chun HY, Ford A, Kutlubaev MA, et al. Depression, anxiety, and suicide after stroke: a narrative review of the best available evidence. Stroke. 2022 Apr;53(4):1402-10.Texto completo Resumo
259. Tang WK, Wang L, Kwok Chu Wong G, et al. Depression after subarachnoid hemorrhage: a systematic review. J Stroke. 2020 Jan;22(1):11-28.Texto completo Resumo
260. Visser-Meily JM, Rhebergen ML, Rinkel GJ, et al. Long-term health-related quality of life after aneurysmal subarachnoid hemorrhage: relationship with psychological symptoms and personality characteristics. Stroke. 2009 Apr;40(4):1526-9.Texto completo Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal